This test is used to identify Tick-Borne Relapsing Fever pathogens via culture-enhanced PCR (cePCR). The sample is first incubated in media so microorganisms in the blood can grow and multiply, then it is tested by PCR. This test is unavailable for patients over 65 when ordered through physician services.
Hey practitioners! 👋 Join Dr. Aristo Vojdani, PhD, MSc, CLS, for an insightful webinar, "Beyond Exposure: Understanding Immune Reactivity Patterns," on Thursday, August 7 at 12:00 PM EST / 9:00 AM PT.
In this session, you’ll explore how immune reactivity testing may provide additional insights into how the body responds to environmental compounds, food additives, and microbial byproducts. Dr. Vojdani will walk through key Cyrex panels that offer complementary perspectives to traditional exposure assessments, supporting clinicians in recognizing immune response patterns that may inform personalized wellness and functional care strategies.
Register now to secure your spot.
.png)
.svg){kind=small}
.svg){kind=small}
